CLINICAL_TRIALS ClinicalTrials.gov record update

A 6-Week Feasibility Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00967993
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:47.706059+00:00
Published At: 2014-11-18T00:00:00+00:00
Record Updated At: 2014-12-05
Results Posted At: 2014-11-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hyperphosphatemia", "End-stage Renal Disease", "Renal Failure Chronic Requiring Hemodialysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-12-05"
protocolSection.identificationModule.nctId: "NCT00967993"
protocolSection.identificationModule.officialTitle: "A 6-Week Feasibility Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-11-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.